Medicine Is Making
Real Progress

A major breakthrough treatment for sickle cell disease has been achieved in Detroit, offering hope to patients with this serious blood disorder.

Sequential raises funding for AI-powered platform discovering novel ingredients for skin health applications.

Landmark study enrollment of Down syndrome participants expands Alzheimer's research to underrepresented populations.

Ingredion and Shiru use AI to discover novel proteins that advance gut health benefits.

A Shanghai firm's innovative diabetes drug gains approval in Hong Kong, offering patients a new treatment option.

New partnership expands Alzheimer's research capabilities and potential treatments.

A simple nasal swab test can now detect early Alzheimer's signals, enabling earlier diagnosis and intervention.

Novel therapy shows breakthrough early results for treating autoimmune diseases.

Innovative data platform improves prediction and understanding of Alzheimer's disease progression.

Google's healthcare innovations are advancing from research labs into real-world clinical settings, improving patient care delivery.

Federal regulators commit to improving and streamlining approval processes for gene therapies treating rare diseases.

Pfizer reports positive success results for atirmociclib in oncology pipeline development.

Parents advocate for expedited access to life-saving medications for children with rare genetic diseases.

Scientists unlock the mechanism behind an Alzheimer's drug, advancing understanding of treatment effectiveness.

First-ever perioperative immunotherapy approved in EU offers new hope for early gastric cancer patients.

Researchers develop methods to diagnose Alzheimer's disease combined with difficult-to-identify dementia types.

A US donation is funding research into a potential new treatment approach for rheumatoid arthritis.

New room-temperature stable tetanus and diphtheria vaccine improves global vaccine accessibility.

University celebrates scientific discoveries and research achievements advancing healthcare.

Medical student inspired by personal experience pursues psychiatric research to help others.

Researchers have identified a promising new treatment pathway that offers hope for Rett Syndrome, a rare disorder without current cures.

Scientific breakthrough enables effective slowing of Huntington's disease progression.

Community science initiatives foster inclusivity and accelerate medical discovery through public participation and curiosity.

A bold new treatment plan shows genuine promise for finally curing type 1 diabetes in humans.

Major innovation breakthrough achieved in Alzheimer's disease pharmaceutical development.

An innovative medical breakthrough now allows many patients to avoid the risks and recovery time associated with open heart surgery.

Data science is being harnessed across Africa to drive health discoveries and medical innovation for the continent.

New cell engineering technology shows promising results in preventing Type 1 diabetes development.

A universal nasal spray vaccine offers protection against three major respiratory diseases in one dose.

FDA streamlines approval process for gene therapies, accelerating life-saving treatments to patients.

FDA announces plans to accelerate approval timelines for rare disease treatments, benefiting patients in need.

Gene therapy successfully restores critical function in cystic fibrosis patients, offering hope for improved quality of life.

FDA approval of new bipolar disorder and schizophrenia treatment offers patients an additional therapeutic option.

FDA streamlines drug approval process with single-study requirement, potentially bringing life-saving treatments to patients faster.

The FDA has approved a new treatment option for patients with locally advanced pancreatic cancer, offering additional hope.

A drug combination successfully blocks tumor resistance in pancreatic cancer models, offering potential new therapeutic strategy.

Important discovery linking multiple body systems advances heart attack prevention understanding.

AI-enabled clinical improvements demonstrate rising success rates, validating biotech innovation for better patient outcomes.

Dana-Farber Cancer Institute highlights ten cancer-related breakthroughs that are generating hope and progress for patients in 2026.

Five breakthrough areas in breast cancer research from 2025 demonstrate meaningful progress in understanding and treating the disease.

Multiple research breakthroughs bring hope for Huntington's disease treatments on the horizon.

Researchers are developing methods to diagnose CTE before death, offering hope for better patient outcomes.

Cancer experts predict significant research and treatment advances in 2026, offering optimism for improved patient outcomes.

mRNA vaccine technology shows promise in advancing prostate cancer treatment options.

Scientists develop innovative approach to reprogram immunity and potentially cure Type 1 diabetes.

Two promising new Parkinson's therapies advance to final clinical trial stages, bringing hope to patients.

Six new cancer therapies approved by FDA in December 2025, expanding hope for cancer patients.

A comprehensive overview of 2025 FDA approvals highlights numerous new treatment options for patients.

Top FDA approvals of 2025 highlight significant advances in pharmaceutical innovation and patient care.

Groundbreaking research demonstrates full neurological recovery from Alzheimer's disease in animal models, not just prevention.

Researchers discover innovative approaches to treat longstanding heart and brain disease challenges in 2025.

Cancer research in 2025 shows increased funding, new treatment options, and innovative breakthrough ideas advancing the field.

Five major shifts in cancer research and care for 2026 are poised to redefine survival outcomes and access for patients.

Gene therapy breakthrough offers new hope for patients with hereditary spastic paraplegia.

Multiple new cancer drugs approved in 2025 from leading cancer research institution offer patients new hope.

Bladder cancer therapy expands FDA approval, bringing treatment access to more patients.

FDA approves innovative new delivery method for spinal muscular atrophy gene therapy, improving accessibility for patients.

Major breakthroughs in Alzheimer's science promise exciting new treatment possibilities.

Baxdrostat receives FDA priority review as a promising new option for patients struggling to control hypertension.